Announced details
Regenerative medicine, PRP therapy, and tissue repair involving joints, tendons, periodontal tissue, skin and other tissues
A business alliance agreement covering the contract processing business for PRP treatments was concluded on 21 July 2026. The companies have now added a capital relationship through the subscription to a third-party allotment.
Headquartered at 35 Shinano-machi, Shinjuku-ku, Tokyo, within Keio University School of Medicine. The representative director and president is Fuw a Junji (不破 淳二). Established in July 2016. The company develops regenerative medicine products, including ASCL-PLC, and operates businesses related to PRP therapy.
35 Shinano-machi, Shinjuku-ku, Tokyo, within Keio University School of Medicine (AdipoSeeds headquarters)
The impact of this matter on our business performance will be immaterial. Over the medium to long term, we believe it will contribute to the growth of our regenerative medicine-related business and enhance corporate value.
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Names of Products / Services Covered | Contract processing services for PRP (Platelet-Rich Plasma) treatments, ASCL-PLC (platelet-like cells derived from human adipose tissue) |
| Counterparty | AdipoSeeds Co., Ltd. |
| Counterparty overview | Headquartered at 35 Shinano-machi, Shinjuku-ku, Tokyo, within Keio University School of Medicine. The representative director and president is Fuw a Junji (不破 淳二). Established in July 2016. The company develops regenerative medicine products, including ASCL-PLC, and operates businesses related to PRP therapy. |
| Relationship with the Company | A business alliance agreement covering the contract processing business for PRP treatments was concluded on 21 July 2026. The companies have now added a capital relationship through the subscription to a third-party allotment. |
| Contract Date | 21 July 2026 (business alliance agreement) |
| Applicable area | Regenerative medicine, PRP therapy, and tissue repair involving joints, tendons, periodontal tissue, skin and other tissues |
| Location | 35 Shinano-machi, Shinjuku-ku, Tokyo, within Keio University School of Medicine (AdipoSeeds headquarters) |
| Impact on Business Performance | The impact of this matter on our business performance will be immaterial. Over the medium to long term, we believe it will contribute to the growth of our regenerative medicine-related business and enhance corporate value. |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To combine AdipoSeeds’ PRP preparation, evaluation and storage technologies with our research and development capabilities in cell culture media, our raw materials and manufacturing support for regenerative medicine, and our contract cell processing business platform, thereby making the companies’ collaboration more effective.